Clinical trial

An Open-label Study of Hydromorphone Oral Solution in Subjects Aged 28 Days to…

NCT00465647 · Purdue Pharma LP, Industry · Completed

Key facts

NCT number NCT00465647
Title An Open-label Study of Hydromorphone Oral Solution in Subjects Aged 28 Days to 16 Years for Postoperative Pain
Official title A Multi-center, Open-label, Dose Titration Study Pharmacokinetics/Pharmacodynamics, Safety, and Efficacy of Hydromorphone Oral Solution in Subjects From 28 Days to 16 Years of Age, Who Require Opioid Analgesics for Postoperative Pain
Acronym Palladone
Lead sponsor Purdue Pharma LP, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Postoperative Pain
Intervention type Drug
Interventions Hydromorphone
Enrollment 116
Start date Apr 1, 2007
Primary completion May 1, 2009
Completion Apr 1, 2010
First posted Apr 25, 2007
Last update posted Nov 18, 2015
Countries United States

At a glance

  • 10–99 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies